Skip to main content
Clinical Trials/NCT04675476
NCT04675476
Recruiting
N/A

A Multilevel Intervention to Address Health Disparities in Lung Cancer Screening

Georgetown University1 site in 1 country368 target enrollmentMarch 11, 2024
ConditionsLung Cancer

Overview

Phase
N/A
Intervention
Not specified
Conditions
Lung Cancer
Sponsor
Georgetown University
Enrollment
368
Locations
1
Primary Endpoint
provider-patient discussion
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

To test the impact of a multilevel intervention on primary (provider-patient communication, intentions, and knowledge) and secondary (screening referrals and completion) outcomes.

Detailed Description

The proposed study will target two key levels of influence in the healthcare setting: provider and patient behavior in order to address disparities between African American and whites in lung screening awareness and utilization. Guided by NIH's Health Disparities Research Framework and building on the formative work conducted in the K99 phase, we will conduct a quasi-experimental study (pretest-posttest, with a nonequivalent control group) in partnership with four primary care clinics within the MedStar Health system in the R00 phase.

Registry
clinicaltrials.gov
Start Date
March 11, 2024
End Date
February 28, 2026
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 50-80 years old;
  • current cigarette smoker or quit within 15 years;
  • a 20+ pack-year smoking history;
  • non-adherent to lung screening (\>13 months);
  • English-speaking;
  • scheduled for an upcoming clinic appointment (4 weeks - 8 weeks); and
  • able and willing to provide meaningful consent and complete telephone interviews

Exclusion Criteria

  • Individuals with a history of lung cancer

Outcomes

Primary Outcomes

provider-patient discussion

Time Frame: 1-week post-visit

Discussion about lung screening with the provider ('did you have a discussion with your doctor about lung screening?')

lung cancer screening knowledge

Time Frame: 1-week post-visit

Lung cancer screening knowledge measure

lung cancer screening intentions

Time Frame: 1-week post-visit

Screening intentions ('how likely is it that you will undergo lung screening in the next 6-months?')

Secondary Outcomes

  • lung cancer screening completion rates(6-months)
  • lung cancer screening referrals(6-months)

Study Sites (1)

Loading locations...

Similar Trials